{"doi":"10.1093/ntr/ntad016","title":"Adoption of E-Cigarettes Among Older Adults Who Smoke to Reduce Harm and Narrow Age-Related Disparities: An Application of the Health Belief Model","abstract":"While the prevalence of combusted cigarette (CC) smoking among all other age groups of U.S. adults decreased between 2005 and 2020, the prevalence for those age ≥55 years remained stagnant.1,2 Indeed, 2021 estimates from the National Health Interview Survey (NHIS) suggest current smoking is as prevalent among adults ages ≥65 years (9.4%; 95% Confidence interval = 8.4, 10.5) as it is among adults ages 18–34 years (9.6%; 95% CI = 8.4, 11.0).3 Smoking in older adults carries burdensome health consequences: Among adults ≥65 years who report current cigarette smoking, 25.7% report smoking-related cancer and 46.9% report another smoking-related chronic disease.4 Furthermore, according to 2017 NHIS data, past-year quit attempts are less prevalent among adults 45–64 years (49.6%) and ≥65 years (47.2%) compared to adults 25–44 years (59.8%) as is the prevalence of quit interest (53.7%, 68.7%, and 72.7%, respectively).5 Older adults struggle with smoking cessation: Only 5% of adults ≥65 years who smoke successfully quit in the past year.4 The tobacco industry has played a role in these rates; they aggressively marketed “light” and “low-tar” cigarettes towards older adults while discouraging quitting and providing cigarettes at senior clubs and nursing homes.6","journal":"Nicotine & Tobacco Research","year":2023,"id":339242,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":16,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.8891,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2023-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":403931,"name":"Rachel Denlinger-Apte","orcid":"0000-0002-3182-7188","position":1,"is_corresponding":false},{"id":282006,"name":"Jennifer Cornacchione Ross","orcid":"0000-0001-5173-3130","position":2,"is_corresponding":false},{"id":523899,"name":"F. Joseph McClernon","orcid":"0000-0002-2846-980X","position":3,"is_corresponding":false},{"id":488488,"name":"Dana Rubenstein","orcid":"0000-0003-4103-9641","position":0,"is_corresponding":true}],"reference_count":19,"raw_metadata":null,"created_at":"2026-07-19T01:10:45.048445Z","pmid":"36702774","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}